2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Cirrhoses, Liver: new trials by email Literature Review of Cirrhoses, Liver trials Research Report on Cirrhoses, Liver
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial Vonoprazan 20 mg, Placebo - Cirrhoses, Liver | Phase 2 | Recruiting | King Edward Medical University | 154 | 2025-12-16 | 2025-12-26 |
| Allopurinol and Pathogenesis of Cirrhosis Allopurinol Tablet, Placebo - Cirrhoses, Liver | Phase 1 / Phase 2 | Completed | Tanta University | 110 | 2023-06-01 | 2026-10-19 |
| Simvastatin Plus Rifaximin in Decompensated Cirrhosis Simvastatin 20 mg, Simvastatin 40mg, Rifaximin 400 mg - Cirrhoses, Liver | Phase 2 | Completed | Judit Pich | 44 | 2017-07-26 | 2019-03-28 |
Esophageal and Gastric Varices (1) · Fibrosis (1) · Hypertension, Portal (1)
Digestive System Diseases (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1) · Allopurinol (1) · Rifaximin (1) · Simvastatin (1)
Judit Pich (1) · King Edward Medical University (1) · Tanta University (1)
Egypt (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Pakistan (1) · Spain (1) · United Kingdom (1)
2016 (1)